News and Events

Chimeric Therapeutics announces partnership with Achieve Clinics to proactively apherese colorectal, gastric and certain neuroendocrine patients in support of their ongoing trial.

Achieve Clinics wins 2nd place out of over 100 companies to secure investment from SDAC, which is quickly doubled by additional follow-on investments. Pre-seed round is now closed.

Cancer Choices is a fantastic patient advocacy group with a focus on integrative medicine approaches. Here, Brad wrote a blog post to alert the groups followers to the promises and the challenges of CAR-T cell therapies.

Co-Founders Brad and Paul chat with Dave Whelan of Bioscience LA about Achieve Clinics and the role of Los Angeles in its success.

Despite headwinds in the economy, Achieve Clinics is excited to announce its first investor: Brazen Capital. We are super excited to leverage their industry expertise and put their capital to work.

Brad Heller shares an early vision for Achieve Clinics during and interview with this rare disease advocacy group

Achieve Clinics will be attending SITC this year - send us a message to meet in person!

Achieve Clinics will be attending ASH2023! Shoot us an email to schedule a meeting!

Achieve Clinics will be attending Meeting on the Mesa this year - drop us a line to reach out and schedule a meeting!

Achieve Clinics is excited to attend the 26th Annual ASGCT conference in our hometown. Contact us to schedule a meeting!

Achieve Clinics is excited to attend LABEST 2023 at UCLA. Contact us to schedule a meeting!

Achieve Clinics will be attending Meeting on the Mesa this year - drop us a line to reach out and schedule a meeting!